Panagiotis Malandrakis Selected Research

Panagiotis Malandrakis Research Topics

Disease

24	Multiple Myeloma 03/2024 - 01/2020
8	COVID-19 09/2023 - 01/2021
5	Neoplasms (Cancer) 01/2023 - 01/2020
3	Paraproteinemias (Monoclonal Gammopathy) 02/2024 - 12/2020
3	Immunoglobulin Light-chain Amyloidosis 11/2023 - 01/2023
2	Bone Diseases (Bone Disease) 02/2024 - 07/2021
2	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 01/2022
2	Disease Progression 02/2024 - 01/2022
2	Thrombosis (Thrombus) 02/2024 - 07/2021
2	Plasma Cell Neoplasms 01/2024 - 01/2021
2	Thrombocytopenia (Thrombopenia) 11/2023 - 01/2020
2	Infections 09/2023 - 01/2023
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2022 - 11/2021
2	Hematologic Neoplasms (Hematological Malignancy) 02/2022 - 01/2020
2	Residual Neoplasm 01/2021 - 01/2020
1	Telangiectasis (Telangiectasia) 02/2024
1	Polycythemia (Erythrocytosis) 02/2024
1	Ascites 02/2024
1	Osteolysis 02/2024
1	Hemorrhage 02/2024
1	Fatigue 11/2023
1	Nausea 11/2023
1	Pain (Aches) 09/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2023
1	Neoplasm Metastasis (Metastasis) 03/2023
1	Colorectal Neoplasms (Colorectal Cancer) 03/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Lung Neoplasms (Lung Cancer) 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2022
1	Glucose Intolerance 01/2022
1	Smoldering Multiple Myeloma 01/2022
1	Hyperglycemia 01/2022
1	Obesity 01/2022
1	Osteoporosis 07/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Kidney Diseases (Kidney Disease) 10/2020
1	POEMS Syndrome (Syndrome, POEMS) 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020

Drug/Important Bio-Agent (IBA)

8	Neutralizing AntibodiesIBA 09/2023 - 01/2021
7	daratumumabIBA 01/2024 - 01/2020
7	VaccinesIBA 09/2023 - 01/2021
7	BNT162 VaccineIBA 10/2022 - 01/2021
6	Lenalidomide (CC 5013)FDA Link 03/2024 - 01/2020
5	belantamab mafodotinIBA 02/2024 - 01/2021
5	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2021
4	AntibodiesIBA 09/2023 - 07/2021
4	MicroRNAs (MicroRNA)IBA 01/2023 - 07/2021
3	Monoclonal AntibodiesIBA 09/2023 - 01/2020
3	carfilzomibIBA 02/2022 - 01/2020
3	ChAdOx1 nCoV-19IBA 11/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2024
2	Immunomodulating AgentsIBA 01/2024 - 01/2020
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 07/2023 - 08/2022
2	Bortezomib (Velcade)FDA Link 02/2022 - 10/2020
2	Proteasome InhibitorsIBA 02/2022 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 12/2020
1	Immunoglobulin M (IgM)IBA 02/2024
1	Transfer RNA (tRNA)IBA 02/2024
1	CreatinineIBA 02/2024
1	AlbuminsIBA 02/2024
1	Circular RNAIBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	cilgavimab and tixagevimab drug combinationIBA 09/2023
1	cilgavimabIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	tixagevimabIBA 09/2023
1	B-Cell Maturation AntigenIBA 07/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Ritonavir (Norvir)FDA Link 01/2023
1	molnupiravirIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	nirmatrelvirIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022
1	ixazomibIBA 02/2022
1	mRNA VaccinesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Circulating MicroRNAIBA 07/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2020
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	selinexorIBA 01/2020

Therapy/Procedure

16	Therapeutics 03/2024 - 10/2020
2	Drug Therapy (Chemotherapy) 02/2024 - 08/2021
2	Metastasectomy 03/2023 - 01/2023
2	Immunotherapy 01/2023 - 12/2022
1	Drug Tapering 11/2023
1	Stem Cell Transplantation 09/2023
1	Hematopoietic Stem Cell Mobilization 09/2023
1	Autologous Transplantation 08/2021